Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tine Jess

Showing results (11-20 of 263) with videos related to

Pageof 27
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
ReplyEdward L Barnes, Tine Jess
World Journal of Gastroenterology|November 28, 2013
Has the risk of colorectal cancer in inflammatory bowel disease decreased?Nynne Nyboe Andersen, Tine Jess
World Journal of Gastrointestinal Pathophysiology|August 19, 2014
Risk of cardiovascular disease in inflammatory bowel diseaseNynne Nyboe Andersen, Tine Jess
Gastroenterology|November 24, 2015
The Changing Landscape of Inflammatory Bowel Disease: East Meets WestGilaad G Kaplan, Tine Jess
Gut|May 25, 2023
Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' replyAdam S Faye, Tine Jess
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
ReplyEdward L Barnes, Tine Jess
Gastroenterology|December 24, 2024
ReplyJonas J Rudbaek, Tine Jess
Nature Reviews. Gastroenterology & Hepatology|December 19, 2012
IBD: Can TNF inhibitors be administered during the third trimester?Ole Haagen Nielsen, Tine Jess
World Journal of Gastroenterology|December 5, 2014
Risk of infections associated with biological treatment in inflammatory bowel diseaseNynne Nyboe Andersen, Tine Jess
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2019
Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in DenmarkJohan Burisch, Tine Jess, Alexander Egeberg
Pageof 27

Showing results (11-20 of 263) with videos related to

Sort By:
Pageof 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
ReplyEdward L Barnes, Tine Jess
World Journal of Gastroenterology|November 28, 2013
Has the risk of colorectal cancer in inflammatory bowel disease decreased?Nynne Nyboe Andersen, Tine Jess
World Journal of Gastrointestinal Pathophysiology|August 19, 2014
Risk of cardiovascular disease in inflammatory bowel diseaseNynne Nyboe Andersen, Tine Jess
Gastroenterology|November 24, 2015
The Changing Landscape of Inflammatory Bowel Disease: East Meets WestGilaad G Kaplan, Tine Jess
Gut|May 25, 2023
Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' replyAdam S Faye, Tine Jess
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
ReplyEdward L Barnes, Tine Jess
Gastroenterology|December 24, 2024
ReplyJonas J Rudbaek, Tine Jess
Nature Reviews. Gastroenterology & Hepatology|December 19, 2012
IBD: Can TNF inhibitors be administered during the third trimester?Ole Haagen Nielsen, Tine Jess
World Journal of Gastroenterology|December 5, 2014
Risk of infections associated with biological treatment in inflammatory bowel diseaseNynne Nyboe Andersen, Tine Jess
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2019
Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in DenmarkJohan Burisch, Tine Jess, Alexander Egeberg
Pageof 27